Scores of genetic markers associated with prostate-cancer risk have been discovered to date, but their clinical utility remains unclear.
No takes yet. Share an insight, caveat, or question.
Pomerantz et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: